ARTICLE | Company News
DuPont gets approval for Sustiva
February 10, 2000 8:00 AM UTC
DD received full FDA approval for Sustiva efavirenz, a once-daily non-nucleoside reverse transcriptase inhibitor, to treat HIV infection. Sustiva had previously received accelerated FDA approval. ...